Effects of inhibitors and stimulators of protein synthesis on the cerebral actions of L-dopa.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002421:Caudate Nucleus / Q000502:physiology / Q000601:surgery; D002701:Chloramphenicol / Q000494:pharmacology*; D003513:Cycloheximide / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000378:metabolism* / Q000494:pharmacology; D013006:Growth Hormone / Q000494:pharmacology*; D008297:Male; D008750:Methyldopa / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D009536:Niacinamide / Q000494:pharmacology*; D011691:Puromycin / Q000494:pharmacology*; D013997:Time Factors
D009419:Nerve Tissue Proteins; D003609:Dactinomycin; D009536:Niacinamide; D011691:Puromycin; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D002701:Chloramphenicol; D013006:Growth Hormone; D003513:Cycloheximide